SARS-COV-2 human monoclonal antibody therapy update [electronic resource] / James E. Crowe.
Material type:
SoundSeries: Henry Stewart talksBiomedical & life sciences collection. Interviews on Covid-19: Publisher: London : Henry Stewart Talks, 2021Description: 1 online resource (1 streaming audio file (11 min.))Subject(s): Antiviral agents -- Development | Coronavirus infections -- Chemotherapy | Coronavirus infections -- Immunological aspects | COVID-19 (Disease) -- Research | COVID-19 (Disease) -- Treatment | Drug development | Monoclonal antibodies -- Research | Monoclonal antibodies -- Therapeutic use | Antibodies, Monoclonal -- pharmacology | Antibodies, Monoclonal -- therapeutic use | Antibodies, Neutralizing | Antiviral Agents | Betacoronavirus -- drug effects | COVID-19 -- drug therapy | COVID-19 -- immunology | Drug Discovery | Immunotherapy | Neutralization Tests | Pandemics | SARS-CoV-2 -- drug effectsOnline resources: Click here to access online | Series Audio interview.
Title from title frames.
Contents: Review of the research done since the start of the pandemic -- Current work covering the SARS-CoV-2 variants -- The selection process of monoclonal antibodies for development -- Next steps in the research and future strategies -- The AHEAD100 project i.e. generating neutralizing antibodies for the 100 most likely causes of future epidemics.
Access restricted to subscribers.
Mode of access: World Wide Web.